Andy is Co-founder, President, and Chief Operating Officer of GentiBio. Prior to joining GentiBio, Dr. Walker was Chief Executive Officer of Jewel Biotherapeutics and formerly Senior Vice President of Technical Operations at Juno Therapeutics, as well as serving in multiple senior leadership roles at AGC Biologics. He is an experienced senior leader overseeing Process Development and GMP manufacturing of cellular therapeutics and protein biologics. Dr. Walker received his B.S. in Chemical Engineering from the University of Washington and his Ph.D. in Chemical engineering from the University of California, Berkeley. In his free time, Andy is an avid fly fisherman, loves all things about the University of Washington (Go Dawgs!), and prefers to spend as much time as possible on a boat or in the mountains.  He also thinks he is funny, but his coworkers tend to disagree.

Chandra is Co-founder and Vice President of Research and Development Operations for GentiBio. Prior to joining GentiBio, Chandra was the Director of Project Management at Casebia Therapeutics focused on the Autoimmune Disease portfolio and supporting HSC and in vivo liver-directed gene editing approaches. Previously, he spent over a decade as a scientist in various research and leadership roles of increasing responsibility at Bayer HealthCare, starting in enzymology and protein engineering and transitioning to non-malignant hematology lab head and research project team lead for multiple projects from discovery to IND stage. He started his career in industry working on next-generation PCR and sequencing technologies at Applied Biosystems. Chandra received his B.S. in Molecular Biology from the University of Texas at Austin and his Ph.D. in Pharmaceutical Sciences from the University of Kentucky.